SwampFox

6th Annual Charlotte Biotechnology Conference

www.CharlotteBiotechnology.com

Join us for the sixth annual Charlotte Biotechnology Conference at UNC Charlotte's Barnhardt Activity Center on Friday, October 12, 2007. The one-day conference will feature perspectives from:

• Charlotte’s Top Biotechnology News Makers
• Regional Biotech and Manufacturing Business Success Stories
• Global Biotechnology Investors
• Scientific and Research Demonstrations
• Biotechnology’s Economic Impact on the Charlotte Region

The Charlotte Biotechnology Conference offers an interactive exchange among universities, government, economic development agencies, research organizations, students, biotechnology companies, and investment professionals. You will gain insight into biotechnology trends, products, services, and partnerships. Please join us to learn more about the emerging biotechnology cluster in the greater Charlotte region.

7:30-8:30 am Registration, Networking & Breakfast

8:30-8:35 am Opening Remarks
David H. Dunn, Vice Chancellor for University Relations and Community Affairs, UNC Charlotte

8:35-9:00 am Business Leaders Panel: A View From the Top

Charlotte is the second largest financial center in the United States, trailing only New York City in terms of holdings of financial assets. As a result, the region’s population has increased by more than 70% in the past decade. Over 170,000 new jobs have been created since 1990, netting over $18 billion in investment. Specific to the biotechnology industry, Medical Equipment and Pharmaceutical Manufacturing have grown significantly. Today, Charlotte is home to approximately 45 companies specializing in Medical Device Manufacturing and another 40 companies who specialize in Pharmaceutical Manufacturing. In the fall of 2006, construction began on the historic North Carolina Research Campus, a $1.5 billion dollar public-private joint venture designed to boast the most technologically advanced biotechnology campus in the country. The 350+ acre complex is expected to generate more than 30,000 jobs within two decades, transforming the once textile-based town of Kannapolis into a world leader in biotechnology research, development and commercialization.

Moderator:
• Chris William, Senior Executive Consultant in the Private Client Group, Wachovia Securities
Panelists:
• Ronnie Bryant, CEcD, FM, President and CEO, Charlotte Regional Partnership
• John Cox, President and CEO, Cabarrus Economic Development Corporation
• Patrick McCrory, Mayor, City of Charlotte
• Clyde Higgs, Vice President for Business Development, North Carolina Research Campus
• Dr. Robert Wilhelm, Executive Director - Charlotte Research Institute, UNC Charlotte

9:00-10:00 am Panel & Presentations - Collaboration is Key: UNC Charlotte’s Partners in Biomedical Engineering, Medical Devices, Translational Research, Cancer and Orthopedics

With nearly $40M in annual research expenditures, the UNC Charlotte is the fastest growing public research institution in North Carolina. UNC Charlotte’s progressive research and activities have garnered local, regional, national and international acclaims. This panel will explore the most recent partnerships and collaborations between the UNC Charlotte and a host of key strategic partners, service providers and primary care networks.

Moderator:
• Carl P. B. Mahler II, Executive Director - Office of Technology Transfer, UNC Charlotte
Panelists:
• Dr. Herbert Bonkovsky, Vice President – Cannon Research Center, Carolinas Medical Center
• Dr. Mark Clemens, Professor and Vice Chair for Research, UNC Charlotte
• Dr. Robin Coger, Director – Center for Biomedical Engineering Systems (CBES), UNC Charlotte
• Dr. Steven Wallenhaupt, Executive Vice President & Chief Medical Officer, Presbyterian Healthcare/Novant Health

10:00-10:15 am Morning Break & Networking

10:15-11:15 am Panel & Presentations – Spotlight on the North Carolina Research Campus
Considered by many to be the largest start-up ventures in the history of North Carolina, the North Carolina Research Campus has captured the interest of the local, national and international biotechnology community. The collaborative spirit required to create such a venture is truly unprecedented. Learn as our distinguished panel of leaders describe their niche and role at the North Carolina Research Campus. Audience members will sample each center’s respective areas of expertise, its impact on biotechnology, how outside companies/entrepreneurs can become engaged with the center(s) and needs of interest in order to expand their research, development and commercialization efforts .

Moderator:
• Dr. Barry L. Burks, Associate Director – Charlotte Research Institute, UNC Charlotte
Panelists:
• Dr. Ken R. Harewood, Director – Biomedical/Biotechnology Research Institute, North Carolina Central University
• Jana Harrison, Deputy Director – School of Public Health’s Nutrition Research Institute, UNC Chapel Hill
• Dr. Steve Lommel, Director – Institute for Fruits and Vegetable Science, North Carolina State University
• Dr. Lawrence Mays, Director – Bioinformatics Research Center, UNC Charlotte
• Dr. Ramu Rao, Director – Center of Excellence for Post-Harvest Technology, North Carolina A&T State University
• Dr. Rosemary Wander, Associate Provost for Research and Public/Private Partnerships, UNC Greensboro

11:15-11:45 am Long Afternoon Break - Poster Judging and Networking

Fifteen university student-based teams from throughout the region will compete for cash prizes on who can present the best “poster” demonstrating their research and commercialization viability. This break gives the judges an opportunity to meet with each team individually and allows for non-judges to network with other attendees.

11:45-1:00 pm Lunch, Keynote & Networking

Art of Identity: The Importance of Building a Global Biotechnology Brand
Charlotte is home to one of the top biotechnology branding and marketing firms in the world. Addison Whitney’s partial lists of clients include global giants such as Abbot, Baxter, Bristol-Myers Squibb, Johnson & Johnson, Pfizer and GlaxoSmithKline. Clayton Tolley will take the audience through the entertaining and educational process by which medical devices, pharmaceuticals and biotechnology manufacturers transform complex and often niche products into well known consumer brands. Properly building brand loyalty, awareness, associations and other attributes can propel the years of research into a viable commercialized product.

Keynote:
• Clayton D. Tolley, President & CEO, Addison Whitney

1:00-2:15 pm Research Presentations

Representative faculty members of the previously highlighted UNC Charlotte Centers and the NC Research Campus Institutes will provide 10-minute slide presentations. Audience members will have an opportunity to gain direct insight into the leading science being conducted, potential partnerships and viable commercial opportunities.

Presentations:
• Dr. Anthony Fodor, Assistant Professor – Bioinformatics/Computer Science, UNC Charlotte
Topic: Biological Dark Matter: Exploring Microbial Diversity with Functional Genomics

• George McAllister, Regional Director - Small Business Technology Development Center, UNC Charlotte
Topic: North Carolina’s Inception Micro Angel Fund (IMAF)

• Dr. Gregory J. Cole, Director – Neuroscience Research Program & Professor of Biology for the Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University
Topic: Neurodegenerative Disease Modeling in Zebrafish

• Dr. Ed Otto, Director of Biotechnology, Rowan-Cabarrus Community College
Topic: Building a Biotechnology Workforce
• Dr. Mitch Cordova, Chair – Department of Kinesiology, UNC Charlotte
Topic: Knee Osteoarthritis: Functional Consequences of a Worn-out Joint

• Dr. John Cavanagh, Professor of Biochemistry, North Carolina State University
Topic: Eradicating Biofilms

• Dr. Patrick Moyer, Associate Professor – Department of Physics and Optical Science, UNC Charlotte
Topic: Optical Microscopy Meets the Nanoscale in Bio-Imaging

2:15-3:00 pm Panel - Regional Biotechnology Business Success Stories

As biotechnology research and investment continues to grow exponentially, the successful formation of start-up companies is a critical piece to diversifying and expanding the Charlotte region’s global biotechnology footprint. This panel will feature local successful entrepreneurs, executives and CEOs of Charlotte’s most promising emerging biotechnology companies. Learn how to successfully navigate a prototype into fully functional manufactured goods, best methods and practices in how to expand product lines and how to attract and retain a high quality work force. Executives will also share their insights on what elements of the Charlotte region helped to make them successful and what they would like to see the region do in order to improve.

Moderator:
• Fred Tannenbaum, Staff Writer, Charlotte Business Journal
Panelists:
• Kevin Drake, Vice President of Regulatory Affairs, Microban International, Ltd.
• Douglas Harris, Vice President of Sales and Marketing, Greiner Bio-One
• Marc Richelsoph, President and CEO, Intelligent Implant Systems, LLC

3:00-3:15 pm Afternoon Break & Networking

3:15-4:00 pm Panel - Financing Successful Biotech Companies
Money is often referred as the “jet fuel” for any start-up business. In the biotechnology sector, this statement could not be more accurate. Access to early stage capital and developing a community that understands the unique circumstances, timelines and requirements to foster a vibrant biotechnology start-up community is crucial. This panel will explore the funding of successful biotechnology start-ups built around university-based research using private equity. Audience members should prepare for a “case study” model on how these companies were formed, the dynamics of founding a company around university-based research and what both investors and university researchers should anticipate prior to forming a partnership.

Moderator:
• Scott Carlberg, Project Director - Open For Business Initiative, UNC Charlotte
Panelists:
• Garheng Kong, General Partner, Intersouth Partners
• Sean McCarthy, Principal, Pappas Ventures
• Clay Thorp, General Partner, Hatteras Venture Partners